The proposed work wil focus on two proteins, the glucocorticoid receptor and ligandin. Since the first monoclonal antibodies to these proteins have now been obtained in this laboratory, we propose to develop a repetoire of antibodies in order to quantify the topology of the glucocorticoid receptor and of ligandin. For the receptor, antibodies will be directed, by selective screening procedures, towards the active sites: the steroid binding site and the DNA-binding site as well as to non-active site antigens. The latter will be particularly useful for one-step column chromatographic purification of the receptor. This will permit a host of studies, previously not possible, such as evaluation of direct phosphorylation and dephosphorylation of the receptor as well as other aspects of the activation mechanism. For ligandin, monoclonal antibodies will be developed against the glutathione S-transferase catalytic center, against the non-specific ligand binding site and also against non-active site antigenic groupings. These antibodies will make it possible to localize the genes for ligandin by somatic cell genetic techniques previously not possible with polyclonal antibodies because of unexplained CRMs appearing in a variety of segregating hybrids. Recent experiments have shown a possible relationship between DNA polymerase Alpha and the glucocorticoid receptor. This potential relationship will be explored in detail and studies with other steroid receptors will be included also to determine specificity at the level of the receptor. This work will contribute to our understanding of the mechanism of action of glucocorticoid hormones and of the molecular biology of the ligandin molecule. Monoclonal antibodies to the receptor will make feasible more quantitative techniques for diagnosis of human leukemias which can be treated effectively with glucocorticoids. Monoclonal antibodies to ligandin may provide a new method for detection of specific diseases of human kidney proximal tubular cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK013531-17
Application #
3225075
Study Section
Endocrinology Study Section (END)
Project Start
1978-03-01
Project End
1988-02-29
Budget Start
1986-03-01
Budget End
1987-02-28
Support Year
17
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Temple University
Department
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Bodine, P V; Alnemri, E S; Litwack, G (1995) Synthetic peptides derived from the steroid binding domain block modulator and molybdate action toward the rat glucocorticoid receptor. Receptor 5:117-22
Bodine, P V; Hajdu, J; Litwack, G (1994) A new synthetic ether aminophosphoglyceride exhibits partial modulator activity towards the glucocorticoid receptor. Biochem Biophys Res Commun 203:408-15
Alnemri, E S; Fernandes-Alnemri, T; Nelki, D S et al. (1993) Overexpression, characterization, and purification of a recombinant mouse immunophilin FKBP-52 and identification of an associated phosphoprotein. Proc Natl Acad Sci U S A 90:6839-43
Robertson, N M; Schulman, G; Karnik, S et al. (1993) Demonstration of nuclear translocation of the mineralocorticoid receptor (MR) using an anti-MR antibody and confocal laser scanning microscopy. Mol Endocrinol 7:1226-39
Alnemri, E S; Litwack, G (1993) The steroid binding domain influences intracellular solubility of the baculovirus overexpressed glucocorticoid and mineralocorticoid receptors. Biochemistry 32:5387-93
Hsu, T C; Melchiorre Jr, L P; Maksymowych, A B et al. (1993) Assembly of glucocorticoid receptor and c-JUN homodimer on the promoter of mouse mammary tumor virus-long terminal repeat is influenced by order of addition. Biochem Biophys Res Commun 197:1260-6
Maksymowych, A B; Hsu, T C; Litwack, G (1992) A novel, highly conserved structural motif is present in all members of the steroid receptor superfamily. Receptor 2:225-40
Alnemri, E S; Robertson, N M; Fernandes, T F et al. (1992) Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. Proc Natl Acad Sci U S A 89:7295-9
Schulman, G; Daniel, V; Cooper, M et al. (1992) Characterization of in vitro translated human mineralocorticoid receptor. Structure and activation. Receptor 2:181-94
Schulman, G; Bodine, P V; Litwack, G (1992) Modulators of the glucocorticoid receptor also regulate mineralocorticoid receptor function. Biochemistry 31:1734-41

Showing the most recent 10 out of 22 publications